Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Pharmacokinetics of Antiepileptic Drugs in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

To see complete record on, please visit this link

Id: NCT03632915

Organisation Name: University of Maryland, Baltimore

Overal Status: Completed

Start Date: November 20, 2017

Last Update: October 5, 2021

Lead Sponsor: University of Maryland, Baltimore

Brief Summary: The purpose of the study is to measure levels of any of the following AEDs (levetiracetam, phenobarbital, phenytoin, ketamine, valproic acid, lacosamide) in blood and effluent on critically ill patients receiving CRRT in order to characterize drug pharmacokinetics and optimize dosing strategies in patients on CRRT.

  • Acute Kidney Injury
  • Renal Insufficiency
  • Renal Failure
  • Pharmacokinetics

Total execution time in seconds: 0.17601704597473